12 – 14/10/2023

Thessaloniki Concert Hall

IASIS PHARMA participated in the “44th PANHELLENIC CONGRESS OF CARDIOLOGY” which held on October 12-14, 2023, at Thessaloniki Concert Hall.

The conference was organized by the Hellenic Society of Cardiology (HSC).

The Panhellenic Congress of Cardiology has established among Cardiologists and the Pharmaceutical Industry, as the Scientific Conference par excellence, with the largest participation of renowned Greek Scientists (Speakers, Presidents), high level of submitted abstracts and published poster presentations.

IASIS PHARMA presented at its exhibition stand the products:

  •  RamiAmlo®/ Ramipril & Amlodipine, the original fixed dose combination of angiotensin-converting enzyme inhibitors with calcium channel blockers. Therapeutic indication, substitution therapy in patients whose blood pressure is adequately controlled with ramipril and amlodipine simultaneously at the same dose level. (Box of 28 caps, Ramipril / Amlodipine: 5mg / 5mg, 5mg / 10mg, 10mg / 5mg, 10mg / 10mg).
  •  RamiAmlo plus®/ the original fixed dose combination of Ramipril – Amlodipine – Hydrochlorothiazide, indicated for the treatment of Hypertension. (Box of 30 caps, Ramipril / Amlodipine / Hydrochlorothiazide: 5 mg / 5 mg / 12,5 mg, 5 mg / 5 mg / 25 mg, 10 mg / 5 mg / 25 mg, 10 mg / 10 mg / 25 mg).
  •  Licepler®/ Eplerenone: Licepler is specifically indicated for the reduction of risk of cardiovascular death in people with heart failure and left ventricular dysfunction ≤40% after a recent acute myocardial infarction, in combination with standard therapies and as treatment against hypertension. (Box of 30 tabs at 25mg & 50mg).
  •  Mag/IASIS®/ 243 mg Magnesium, main indications: Conditions of magnesium deficiency if these cannot be treated through nutrition. Disorders of muscle function, caused by confirmed magnesium deficiency (neuromuscular disorders, muscle cramps, such as gastrocnemius cramps, nocturnal cramps). (Box of 40 eff. tabs).